Schiller GJ - Search Results

1

Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3.

Fischer T, Stone RM, Deangelo DJ, Galinsky I, Estey E, Lanza C, Fox E, Ehninger G, Feldman EJ, Schiller GJ, Klimek VM, Nimer SD, Gilliland DG, Dutreix C, Huntsman-Labed A, Virkus J, Giles FJ. Fischer T, et al. Among authors: schiller gj. J Clin Oncol. 2010 Oct 1;28(28):4339-45. doi: 10.1200/JCO.2010.28.9678. Epub 2010 Aug 23. J Clin Oncol. 2010. PMID: 20733134 Free PMC article. Clinical Trial.

2

Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.

Schiller G, Gajewski J, Territo M, Nimer S, Lee M, Belin T, Champlin R. Schiller G, et al. Blood. 1992 Dec 15;80(12):2977-82. Blood. 1992. PMID: 1467513 Free article. Clinical Trial.

3

A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia.

Schiller G, Gajewski J, Nimer S, Territo M, Ho W, Lee M, Champlin R. Schiller G, et al. Br J Haematol. 1992 Jun;81(2):170-7. doi: 10.1111/j.1365-2141.1992.tb08203.x. Br J Haematol. 1992. PMID: 1643014 Clinical Trial.

4

Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.

Champlin R, Gajewski J, Nimer S, Vollset S, Landaw E, Winston D, Schiller G, Ho W. Champlin R, et al. J Clin Oncol. 1990 Jul;8(7):1199-206. doi: 10.1200/JCO.1990.8.7.1199. J Clin Oncol. 1990. PMID: 1694236 Clinical Trial.

5

Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission.

Schiller GJ, Nimer SD, Territo MC, Ho WG, Champlin RE, Gajewski JL. Schiller GJ, et al. J Clin Oncol. 1992 Jan;10(1):41-6. doi: 10.1200/JCO.1992.10.1.41. J Clin Oncol. 1992. PMID: 1727924

6

Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma.

Schiller G, Nimer S, Vescio R, Lieb G, Lee M, Gajewski J, Territo M, Berenson J. Schiller G, et al. Bone Marrow Transplant. 1994 Jul;14(1):131-6. Bone Marrow Transplant. 1994. PMID: 7951100 Clinical Trial.

7

Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study.

Schiller G, Nimer S, Gajewski J, Lee M, Ho W, Territo M, Champlin R. Schiller G, et al. Leuk Lymphoma. 1993 Sep;11(1-2):69-77. doi: 10.3109/10428199309054732. Leuk Lymphoma. 1993. PMID: 8220156 Clinical Trial.

8

Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia.

Schiller G, Lee M, Territo M, Gajewski J, Nimer S. Schiller G, et al. Am J Hematol. 1993 Jul;43(3):195-9. doi: 10.1002/ajh.2830430307. Am J Hematol. 1993. PMID: 8352235 Clinical Trial.

9

Use of recombinant GM-CSF following allogeneic BMTs for aplastic anemia.

Chap L, Schiller G, Nimer SD. Chap L, et al. Bone Marrow Transplant. 1993 Aug;12(2):173-5. Bone Marrow Transplant. 1993. PMID: 8401368

10

Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia.

Dorr R, Karanes C, Spier C, Grogan T, Greer J, Moore J, Weinberger B, Schiller G, Pearce T, Litchman M, Dalton W, Roe D, List AF. Dorr R, et al. J Clin Oncol. 2001 Mar 15;19(6):1589-99. doi: 10.1200/JCO.2001.19.6.1589. J Clin Oncol. 2001. PMID: 11250987 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters